Stockreport

FDA Authorizes ImmunityBio to Provide Recombinant BCG (rBCG) to Urologists to Address TICE® BCG Shortage [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF Supplies of rBCG are now available, with shipments set to begin immediately via an FDA Expanded Access Program Multiple U.S. patents issued and allowed on combination [Read more]